Back to search

University of Thessaly (UTH)

Κόστος θεραπευτικής αντιμετώπισης των πασχόντων από σύνδρομο αποφρακτικών απνοιών - υποπνοιών κατά τον ύπνο

Abstract

dc:description

Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS) is a pathological condition which disturb the biological phenomenon of sleep, is present in 2-4% of the general population. Unsettles physical, spiritual and mental health and is one of the most satisfactory response, in terms of treatment, medical conditions with an effective and rapid improvement in quality of life of patients.Nowadays, one of the most important policy issues is the rising cost of health care. Recently, in Greece, the existing cost of illness studies are scare, making difficult the detection and the evaluation of the economic consequences of various diseases in order to be able to make sound health policy. This study attempts to constitute towards this direction by creating a detailed cost evaluation of OSAHS.The aim was to investigate the annual cost of patients suffering from OSAHS and identify the potential economic.Patiens and methodsThe study was conducted in the sleep laboratory of Sotiria Chest Hospital in Athens from 1/1/2008 to 31/12/2008. A sample of 340 subjects was screened for OSAHS. Diagnosis was confirmed after polysomnography. Direct medical costs were included in the analysis for the whole study population using the bottom-up approach. Clinical and epidemiological data were derived from patients’ records while economic data was obtained from the finance department of the hospital. Costs related to staff payments, overheads, consumable materials, tools as well as depreciation of the capital and instruments assets have been included in the analysis and the purchase of the ventilation devices (CPAP, BiPAP).ResultsA total of 340 patients, 262 males and 78 females, mean aged 55,9 (±SD12,4) years participated in this study.Mean annual cost reaches approximately €1.685,90 per patient, 15% is paid by NHS, 64% by social funds and 21% by patients’ out-of-pocket payments. Major cost drivers were patient’s treatment (66.55), staff payments (9.8%), overheads (2.45%).Variations are found in the patients’ coverage related to the purchase of both devices. Patients’ out of pocket spending for the purchase of the BiPAP ranges from 5% to 48.6% and of the CPAP from 0% to 33,5% depending on the social fund in which the patient belongs. ConclusionsMean annual cost of treating patients with therapy reaches approximately 1685,90€. Variations are found among patients’ social insurance coverage related to the purchase of both devices as well as severe inequalities in patients’ cost sharing among the various funds.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Πράπα, Παρασκευή-Μαρία

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27827

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Πράπα, Παρασκευή-Μαρία. Κόστος θεραπευτικής αντιμετώπισης των πασχόντων από σύνδρομο αποφρακτικών απνοιών - υποπνοιών κατά τον ύπνο. University of Thessaly (UTH), 2012. http://hdl.handle.net/10442/hedi/27827